Athena Drug Delivery Solutions Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Athena Drug Delivery Solutions Private Limited Pharmaceutical Export Portfolio Dataset — 6 Products, $10.0M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Athena Drug Delivery Solutions Private Limited — Pharmaceutical Exporter Profile (2026) | 6 Products, $10.0M Trade | TransData Nexus

Athena Drug Delivery Solutions Private Limited

Indian Pharmaceutical Exporter · Gastrointestinal Specialist · $10.0M Total Trade · DGFT Verified

Athena Drug Delivery Solutions Private Limited is an Indian pharmaceutical exporter with a total trade value of $10.0M across 6 products in 4 therapeutic categories. Based on 225 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ondansetron ($3.8M), Fenofibrate ($3.4M), Secnidazole ($850.0K).

Athena Drug Delivery Solutions Private Limited — Export Portfolio & Destination Treemap

Athena Drug Delivery Solutions Private Limited pharmaceutical export portfolio — 6 products across 4 therapeutic categories. Source: Indian Customs (DGFT).

Who is Athena Drug Delivery Solutions Private Limited? — Company Overview & Market Position

Athena Drug Delivery Solutions Private Limited, established on November 16, 1995, is a private pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company specializes in the development and manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. With an authorized capital of ₹50.75 crore and a paid-up capital of ₹27.83 crore, Athena operates as a non-government, unlisted entity.

The company's Corporate Identification Number (CIN) is U24230MH1995PTC094546, and it is registered under the Registrar of Companies, Mumbai. As of the latest available data, Athena employs approximately 178 professionals. The company's registered office is located at 602, 6th Floor, Tower-II, 'Star Hub' International Airport Road, Sahar, Andheri (E), Mumbai, Maharashtra, 400059, India.

What Does Athena Drug Delivery Solutions Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Ondansetron$3.8M 2

Product Portfolio — Top 6 by Export Value

Athena Drug Delivery Solutions Private Limited exports 6 pharmaceutical products across 4 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ondansetron	Gastrointestinal	$3.8M	102	3.1%	9
2	Fenofibrate	Lipid & Metabolism	$3.4M	68	4.6%	5
3	Secnidazole	Advanced Antibiotics	$850.0K	17	2.8%	4
4	Meloxicam	Analgesics & Antipyretics	$750.0K	15	0.4%	10
5	Mesalamine	Gastrointestinal	$750.0K	15	0.1%	7
6	Ketorolac	Analgesics & Antipyretics	$400.0K	8	0.3%	11

Athena Drug Delivery Solutions Private Limited exports 6 pharmaceutical products across 4 therapeutic categories with a total export value of $10.0M. The top category is Gastrointestinal (45.8% of portfolio), followed by Lipid & Metabolism (34.1%), indicating a concentrated portfolio with the top 5 products accounting for 96.0% of total export value.

Athena Drug Delivery Solutions Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Athena Drug Delivery Solutions Private Limited operates a manufacturing facility in Ambernath, approximately 60 kilometers north of Mumbai, India. This facility is approved for European Union Good Manufacturing Practice (EU GMP), indicating compliance with stringent international quality standards. The plant specializes in the production of oral drug delivery systems, including effervescent tablets, oro-dispersible tablets, and modified drug release formulations. These products cater to therapeutic areas such as pain management, central nervous system disorders, cardiometabolic conditions, gastroenterology, and gynecology.

3Key Leadership

The leadership team at Athena Drug Delivery Solutions Private Limited comprises several key individuals:

Mahendra Baliram Chaudhari: Managing Director since April 10, 2018.

Alexandre Luc Williams: Whole-Time Director since March 8, 2011.

Maryline Williams: Director since April 6, 2017.

Tejas Ravikant Gawade: Company Secretary since April 16, 2018.

Subhash Kumar Madhavan Thalodil: Chief Financial Officer since November 8, 2023.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Athena Drug Delivery Solutions Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Athena Drug Delivery Solutions Private Limited has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facility in Ambernath holds EU GMP certification, facilitating access to European markets. While specific regulatory approvals in the United States, United Kingdom, Australia, and Japan are not detailed in the available sources, the EU GMP certification suggests a commitment to meeting international quality standards, which is often a prerequisite for market entry in these regions.

2Emerging Markets

Athena Drug Delivery Solutions Private Limited has expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's focus on developing lifecycle products and its broad range of technology platforms for oral delivery, including modified release formulations and oro-dispersible dosage forms, position it well to meet the diverse needs of these regions. Additionally, the EU GMP certification of its manufacturing facility in Ambernath enhances its ability to meet international quality standards, facilitating access to these emerging markets.

3Geographic Strategy

Athena Drug Delivery Solutions Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Athena Drug Delivery Solutions Private Limited's interactions with the U.S. Food and Drug Administration (FDA) are not available in the provided sources. The company's EU GMP certification of its manufacturing facility in Ambernath suggests adherence to international quality standards, which is often a prerequisite for market entry in regulated markets like the United States. However, without explicit information on FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history, a comprehensive assessment of the company's FDA status cannot be made.

2WHO & EU GMP

Athena Drug Delivery Solutions Private Limited's manufacturing facility in Ambernath, India, holds EU GMP certification, indicating compliance with European Union Good Manufacturing Practice standards. While the available sources do not specify whether the facility holds World Health Organization (WHO) prequalification, the EU GMP certification suggests a commitment to meeting international quality standards, which is often a prerequisite for obtaining WHO prequalification.

3CDSCO & Indian Regulatory

Athena Drug Delivery Solutions Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Athena Drug Delivery Solutions Private Limited operates in a competitive landscape with several key players in the pharmaceutical industry. While specific market share data is not available in the provided sources, the company's focus on developing lifecycle products and its broad range of technology platforms for oral delivery, including modified release formulations and oro-dispersible dosage forms, position it to compete effectively in therapeutic areas such as pain management, central nervous system disorders, cardiometabolic conditions, gastroenterology, and gynecology.

2Key Differentiators

Athena Drug Delivery Solutions Private Limited differentiates itself through its commitment to developing lifecycle products and its broad range of technology platforms for oral delivery. The company's focus on modified release formulations and oro-dispersible dosage forms allows it to address diverse therapeutic areas, including pain management, central nervous system disorders, cardiometabolic conditions, gastroenterology, and gynecology. Additionally, the EU GMP certification of its manufacturing facility in Ambernath underscores its adherence to international quality standards, enhancing its credibility in the global market.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Athena Drug Delivery Solutions Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Athena Drug Delivery Solutions Private Limited demonstrates a strong track record in the pharmaceutical industry, with a focus on developing lifecycle products and utilizing advanced technology platforms for oral drug delivery. The company's manufacturing facility in Ambernath, India, holds EU GMP certification, indicating adherence to international quality standards. While specific details regarding export volume and consistency are not provided in the available sources, the company's strategic focus on diverse therapeutic areas and its commitment to quality suggest reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications when considering Athena Drug Delivery Solutions Private Limited as a supplier:

EU GMP Certification: Confirm the validity of the EU GMP certification of the manufacturing facility in Ambernath, India, to ensure compliance with European Union Good Manufacturing Practice standards.

WHO Prequalification:

Frequently Asked Questions — Athena Drug Delivery Solutions Private Limited

How many pharmaceutical products does Athena Drug Delivery Solutions Private Limited export from India?

Athena Drug Delivery Solutions Private Limited exports 6 pharmaceutical products across 4 therapeutic categories. The top exports are Ondansetron ($3.8M), Fenofibrate ($3.4M), Secnidazole ($850.0K), Meloxicam ($750.0K), Mesalamine ($750.0K). Total export value is $10.0M.

What is Athena Drug Delivery Solutions Private Limited's total pharmaceutical export value?

Athena Drug Delivery Solutions Private Limited's total pharmaceutical export value is $10.0M, based on 225 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Athena Drug Delivery Solutions Private Limited cover?

Athena Drug Delivery Solutions Private Limited exports across 4 therapeutic categories. The largest are Gastrointestinal (45.8%, 2 products), Lipid & Metabolism (34.1%, 1 products), Analgesics & Antipyretics (11.5%, 2 products).

Get Full Athena Drug Delivery Solutions Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.